Top Medical Stocks To Watch For 2019

Imagine your frail father dons a virtual reality headset so he can “attend” his grandson’s graduation and feel as if he’s really there. Or your mom, forgetful about her medicine, swallows a teensy sensor encased in medication that will relay the time she took the pill and the dosage to her smartphone.

SEE ALSO: Technology Helps Seniors Remain at Home

Perhaps your mother-in-law has dementia, which makes her agitated. A small robot she holds that acts like a cat, including purring, calms her instantly. Afraid shell wander? Your phone can alert you if she does.

Whether already in use or still being tested, aging-in-place technology is improving the aging experience for seniors and family caregivers. Part of the reason: the development of artificial intelligence, or AI, and “big data.” With AI, devices can react like humans after assessing a situation and learning someone’s habits. Wearable gadgetsthink Fitbit on steroidscan collect and analyze health data, while medical mini-machines monitor chronic conditions and customize treatment.

Top Medical Stocks To Watch For 2019: Grifols, S.A.(GRFS)

Advisors’ Opinion:

  • [By Max Byerly]

    Financial Gravity Companies Inc. raised its stake in shares of Grifols (NASDAQ:GRFS) by 264.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 13,862 shares of the biotechnology company’s stock after purchasing an additional 10,054 shares during the quarter. Financial Gravity Companies Inc.’s holdings in Grifols were worth $282,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    Grifols (NASDAQ:GRFS) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.

Top Medical Stocks To Watch For 2019: Retail Properties of America, Inc.(RPAI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Retail Properties of America (RPAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Retail Properties of America Inc. (NYSE: RPAI) investors receive a 5.7% yield. The stock was last seen trading at $11.45 a share. The 52-week range is $10.94 to $14.70, and the consensus price target is $15.44.

  • [By Shane Hupp]

    Press coverage about Retail Properties of America (NYSE:RPAI) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Retail Properties of America earned a news impact score of 0.19 on Accern’s scale. Accern also assigned press coverage about the real estate investment trust an impact score of 48.1880076437209 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top Medical Stocks To Watch For 2019: Tandy Leather Factory, Inc.(TLF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tandy Leather Factory (NASDAQ: TLF) and Vera Bradley (NASDAQ:VRA) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Top Medical Stocks To Watch For 2019: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Deutsche Bank upgraded shares of St. James’s Place (LON:STJ) to a buy rating in a research report released on Thursday. They currently have GBX 1,430 ($19.19) target price on the stock, up from their prior target price of GBX 1,310 ($17.58).

  • [By Stephan Byrd]

    Media headlines about St Jude Medical (NYSE:STJ) have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 46.7237518599623 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top Medical Stocks To Watch For 2019: Enerplus Corporation(ERF)

Advisors’ Opinion:

  • [By Max Byerly]

    Enerplus (TSE:ERF) (NYSE:ERF) had its target price hoisted by CIBC from C$19.00 to C$20.00 in a research note published on Friday morning.

    Other research analysts also recently issued research reports about the stock. CSFB upped their price objective on shares of Enerplus from C$17.00 to C$20.00 in a report on Friday, April 13th. GMP Securities upped their price objective on shares of Enerplus from C$17.00 to C$18.00 in a report on Thursday, March 1st. Barclays upped their price objective on shares of Enerplus from C$18.00 to C$20.00 in a report on Monday, February 26th. Canaccord Genuity upped their price objective on shares of Enerplus from C$16.50 to C$17.00 in a report on Monday, February 26th. Finally, Desjardins upped their price objective on shares of Enerplus from C$16.00 to C$17.50 in a report on Monday, February 26th. Seven equities research analysts have rated the stock with a buy rating, The stock has an average rating of Buy and an average price target of C$18.29.

  • [By Ethan Ryder]

    Enerplus (NYSE:ERF) (TSE:ERF) – Stock analysts at National Bank Financial reduced their FY2018 earnings estimates for Enerplus in a research note issued on Thursday, May 3rd. National Bank Financial analyst T. Wood now forecasts that the oil and natural gas company will earn $1.13 per share for the year, down from their previous estimate of $1.27. National Bank Financial also issued estimates for Enerplus’ FY2019 earnings at $1.96 EPS.

Leave a Reply

Your email address will not be published. Required fields are marked *